Please assess the completion status of the following clinical trial:

Trial Title: Tolerability/PoP Study in Allergic Rhinitis After Intranasal Administration of AZD8848

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a history of birch and/ or timothy grass pollen induced seasonal allergic rhinitis for at least the previous 2 years (verified by a positive skin prick test)~* Patients with need of treatment for their nasal symptoms during the pollen season~Exclusion Criteria:~* Clinical relevant disease or abnormality (past or present) - other than allergic rhinitis~* Symptomatic perennial allergic or non-allergic rhinitis~* A history of asthma

- Gender: MALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).